AI assistant
Sight Sciences, Inc. — Director's Dealing 2025
Nov 27, 2025
33763_dirs_2025-11-26_8fe8a915-acba-4afe-b68a-3f59cde4c197.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2025-11-25
Reporting Person: HAYDEN JEREMY B. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-25 | Common Stock | M | 37560 | $1.96 | Acquired | 294150 | Direct |
| 2025-11-25 | Common Stock | M | 7290 | $1.96 | Acquired | 301440 | Direct |
| 2025-11-25 | Common Stock | S | 44850 | $8.08 | Disposed | 256590 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-25 | Stock Option (Right to Buy) | $1.96 | M | 37560 | Disposed | 2030-05-10 | Common Stock (37560) | Direct |
| 2025-11-25 | Stock Option (Right to Buy) | $1.96 | M | 7290 | Disposed | 2030-07-28 | Common Stock (7290) | Direct |
Footnotes
F1: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with, and pursuant to, the terms of a marital separation agreement previously entered into between the Reporting Person and his former spouse. The Reporting Person's spouse will receive all proceeds from the shares sold in the transactions.
F2: Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan.
F3: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.22, inclusive. The Reporting Person undertakes to provide to the Issuer,
any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The options are fully vested and exercisable.